Lee Brettman

3.5k total citations · 2 hit papers
25 papers, 2.5k citations indexed

About

Lee Brettman is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Genetics. According to data from OpenAlex, Lee Brettman has authored 25 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Epidemiology and 6 papers in Genetics. Recurrent topics in Lee Brettman's work include Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (4 papers) and Kidney Stones and Urolithiasis Treatments (3 papers). Lee Brettman is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (4 papers) and Kidney Stones and Urolithiasis Treatments (3 papers). Lee Brettman collaborates with scholars based in United States, United Kingdom and Netherlands. Lee Brettman's co-authors include Robert S. Holzman, Gary P. Wormser, Ida M. Onorato, Michael F. Michelis, Henry Masur, P. Santabárbara, Susanna Cunningham–Rundles, Michael Lange, Jeffrey B. Greene and Henry W. Murray and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Lee Brettman

25 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Outbreak of Community-AcquiredPneumocystis cariniiPneumonia

1981 1.0k citations Henry Masur, Michael F. Michelis et al. New England Journal of Medicine profile →
Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study

2002 707 citations Michael J. Keating, Peter Hillmen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lee Brettman United States	16	923	843	799	677	500	25	2.5k
Carlos R. Abramowsky United States	31	781 0.8×	142 0.2×	502 0.6×	629 0.9×	729 1.5×	138	3.9k
Patrice Morel France	35	515 0.6×	292 0.3×	933 1.2×	1.3k 1.9×	483 1.0×	123	3.3k
A J Pinching United Kingdom	30	613 0.7×	199 0.2×	181 0.2×	907 1.3×	709 1.4×	59	3.0k
Jean‐Marie Andrieu France	28	953 1.0×	94 0.1×	308 0.4×	511 0.8×	586 1.2×	89	2.8k
Joseph A. Church United States	30	1.3k 1.4×	213 0.3×	108 0.1×	577 0.9×	826 1.7×	182	3.2k
Severin Olesen Larsen Denmark	33	296 0.3×	176 0.2×	412 0.5×	749 1.1×	614 1.2×	133	3.5k
Mary S. Campbell United States	20	203 0.2×	206 0.2×	264 0.3×	312 0.5×	542 1.1×	39	2.2k
P. Kern Germany	30	346 0.4×	78 0.1×	1.3k 1.7×	403 0.6×	589 1.2×	108	3.0k
Richard L. Wasserman United States	34	1.6k 1.7×	845 1.0×	264 0.3×	328 0.5×	161 0.3×	138	3.2k
E. Graham Davies United Kingdom	29	1.6k 1.7×	270 0.3×	144 0.2×	1.6k 2.4×	656 1.3×	71	4.4k

Countries citing papers authored by Lee Brettman

Since Specialization

Citations

This map shows the geographic impact of Lee Brettman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Brettman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Brettman more than expected).

Fields of papers citing papers by Lee Brettman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee Brettman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Brettman. The network helps show where Lee Brettman may publish in the future.

Co-authorship network of co-authors of Lee Brettman

This figure shows the co-authorship network connecting the top 25 collaborators of Lee Brettman. A scholar is included among the top collaborators of Lee Brettman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee Brettman. Lee Brettman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lingeman, James E., Gyan Pareek, Linda Easter, et al.. (2019). ALLN-177, oral enzyme therapy for hyperoxaluria. International Urology and Nephrology. 51(4). 601–608. 26 indexed citations

Langman, Craig B., et al.. (2016). A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading Enzyme. American Journal of Nephrology. 44(2). 150–158. 37 indexed citations

Grujić, Danica, et al.. (2016). PD31-11 ALLN-177 REDUCES HYPEROXALURIA IN A PORCINE MODEL OF SECONDARY HYPEROXALURIA (2°HO) INDUCED BY A HUMAN-LIKE OXALATE RICH DIET. The Journal of Urology. 195(4S). 2 indexed citations

Borowitz, Drucy, Christopher Stevens, Lee Brettman, et al.. (2011). International phase III trial of liprotamase efficacy and safety in pancreatic-insufficient cystic fibrosis patients. Journal of Cystic Fibrosis. 10(6). 443–452. 25 indexed citations

Borowitz, Drucy, et al.. (2010). Reproducibility of coefficient of fat absorption (CFA) in cystic fibrosis patients with pancreatic insufficiency. Journal of Cystic Fibrosis. 9. S77–S77. 3 indexed citations

Mould, Diane R., Andreas Baumann, Jens Kuhlmann, et al.. (2007). Population pharmacokinetics–pharmacodynamics of alemtuzumab (Campath^®) in patients with chronic lymphocytic leukaemia and its link to treatment response. British Journal of Clinical Pharmacology. 64(3). 278–291. 92 indexed citations

Shaw, George H., et al.. (2002). Phenotypic transformation of CD52pos to CD52neg leukemic T cells as a mechanism for resistance to CAMPATH-1H. Leukemia. 16(5). 861–864. 16 indexed citations

Lockwood, C M, Lee Brettman, G Hale, et al.. (1999). Anti-adhesion Molecule Therapy as an Interventional Strategy. Clinical Immunology. 93(2). 93–106. 23 indexed citations

Brettman, Lee & Pravin Chaturvedi. (1996). Pharmacokinetics and Safety of Single Oral Doses of VX‐366 (Isobutyramide) in Healthy Volunteers. The Journal of Clinical Pharmacology. 36(7). 617–622. 6 indexed citations

10.

Nicolle, L. E., David R.P. Guay, D. Revicki, et al.. (1993). EFFICACY OF OFLOXACIN FOR THE TREATMENT OF PNEUMONIA, SKIN AND SKIN STRUCTURE INFECTION, AND URINARY TRACT INFECTION IN AN ELDERLY POPULATION. Infectious Diseases in Clinical Practice. 2(6). 414–422. 3 indexed citations

11.

Brettman, Lee, et al.. (1992). Chronology of a hospital-wide measles outbreak: Lessons learned and shared from an extraordinary week in late March 1989. American Journal of Infection Control. 20(6). 315–318. 14 indexed citations

12.

Brettman, Lee. (1988). Pathogenesis of urinary tract infections: host susceptibility and bacterial virulence factors.. PubMed. 32(3 Suppl). 9–11. 4 indexed citations

13.

Brettman, Lee. (1988). Nosocomial infection: risks associated with short-term and long-term inpatient care.. PubMed. 32(3 Suppl). 21–3. 4 indexed citations

14.

Grace, Christopher, et al.. (1988). Actinobacillus actinomycetemcomitans Prosthetic Valve Endocarditis. Clinical Infectious Diseases. 10(5). 922–929. 31 indexed citations

15.

DeHertogh, Deborah & Lee Brettman. (1988). Hemorrhagic cystitis due to herpes simplex virus as a marker of disseminated herpes infection. The American Journal of Medicine. 84(3). 632–635. 14 indexed citations

16.

Levitz, Robert E., et al.. (1988). Infection with the human immunodeficiency virus (HIV) as a risk factor for bacteremic illness due to Streptococcus pneumoniae.. PubMed. 52(12). 703–4. 8 indexed citations

17.

Klimek, Joseph J., et al.. (1985). A Multi-Hospital Hepatitis B Vaccine Program: Prevalence of Antibody and Acceptance of Vaccination Among High-Risk Hospital Employees. Infection Control. 6(1). 32–34. 21 indexed citations

18.

Masur, Henry, Michael F. Michelis, Ida M. Onorato, et al.. (1982). An Outbreak of Community-Acquired Pneumocystis Carinii Pneumonia. Initial Manifestation of Cellular Immune Dysfunction. The Journal of Urology. 128(2). 436–436. 34 indexed citations

19.

Masur, Henry, Michael F. Michelis, Jeffrey B. Greene, et al.. (1981). An Outbreak of Community-AcquiredPneumocystis cariniiPneumonia. New England Journal of Medicine. 305(24). 1431–1438. 1008 indexed citations breakdown →

20.

Lewin, Sharon R., Lee Brettman, Ellie J. C. Goldstein, et al.. (1979). Legionnaires' disease. The American Journal of Medicine. 67(2). 339–342. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact